PHILADELPHIA, July 5, 2022 – Titan CEO and headline sponsor Wipfli LLP are pleased to announce the 2022 Philadelphia Titan 100. The Titan 100 program recognizes Philadelphia’s Top 100 CEO’s & C-level executives. They are the area’s most accomplished business leaders in their industry using criteria that includes demonstrating exceptional leadership, vision, and passion.
Featured in Clinical Researcher: Scott Gray, CEO discusses the importance of a hybrid approach to decentralized trials for patients with rare diseases.
Healthcare and technology have always gone hand-in-hand. In fact, some of medicine’s earliest innovations are the most enduring. For clinical trials, the convergence of healthcare and technology creates a constant stream of innovation in the pursuit of novel treatments and therapies. Likewise, the pandemic and subsequent growth of decentralized trials demonstrate how technology can play an essential role in the patient experience.
Featured in SCRS InSite Journal: Scott Gray, CEO, reflects on the impact COVID-19 had on the clinical trial industry, including the challenges faced and the swift response of the global healthcare community to ensure patient centricity.
Featured in Applied Clinical Trials: Decentralized trials are the way of the future—yet it would be ill-advised to think of them as a one-size-fits-all solution. While the pandemic increased the industry’s acceptance of decentralized clinical trial protocols, moving to an entirely virtual model without in-person interaction is unrealistic. This sort of hybrid approach allows researchers …
COVID-19 and the Changing Landscape of Clinical Trials Read More »
View the results of our recent research to explore how effective patient support strategies can reduce barriers, increase retention, and improve outcomes in rare disease clinical trials in our latest eBook.
